SENATE 1250118th CongressRead twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)

Drug-price Transparency for Consumers Act of 2023

Last Action: 4/20/2023

Actions

2023-04-20Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)
2023-04-20Introduced in Senate

CRS Summary

As of 2023-04-20 (00)

Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023

This bill requires consumer advertisements for drugs and biologicals to include certain price information if the drug or biological is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. The requirement does not apply to advertisements for drugs or biologicals with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Cosponsors (8)

Chuck Grassley (R-IA)
Angus King (I-ME)
Mike Braun (R-IN)
Richard Blumenthal (D-CT)
J. Vance (R-OH)
Tammy Baldwin (D-WI)
Sherrod Brown (D-OH)
Tina Smith (D-MN)

Subjects

Administrative law and regulatory procedures
Civil actions and liability
Department of Health and Human Services
Health care costs and insurance
Marketing and advertising
Prescription drugs

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.